8,8-Difluoro-2-azaspiro[4.5]decane oxalate(2:1)

Catalog No. :
ACNJQV873
CAS No. :
2007919-26-6
Molecular Formula :
C20H32F4N2O4
Molecular Weight :
440.48

IUPAC Name:8,8-difluoro-2-azaspiro[4.5]decane hemioxalate

8,8-Difluoro-2-azaspiro[4.5]decane oxalate(2:1) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$219.00Login to see priceIn stockInquiry
500mg97%$437.00Login to see priceIn stockInquiry
1g97%$632.00Login to see priceIn stockInquiry
5g97%$1919.00Login to see priceIn stockInquiry
10g97%$3198.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8,8-Difluoro-2-azaspiro[4.5]decane oxalate(2:1)
IUPAC Name8,8-difluoro-2-azaspiro[4.5]decane hemioxalate
MDL No.MFCD30471652
Molecular FormulaC20H32F4N2O4
Molecular Weight440.48
SMILESFC(CC1)(F)CCC21CCNC2.FC(CC3)(F)CCC43CCNC4.O=C(O)C(O)=O
InChI KeyWRUOGZKSNRKCGA-UHFFFAOYSA-N
Synonymbis(8,8-difluoro-2-azaspiro[4.5]decane);BIS(8,8-DIFLUORO-2-AZASPIRO[4.5]DECANE); OXALIC ACID;2-Azaspiro[4.5]decane, 8,8-difluoro-, ethanedioate (2:1);8,8-difluoro-2-azaspiro[4.5]decane;8,8-Difluoro-2-azaspiro[4.5]decane Hemioxalate;hemi(oxalic acid) - [D84492]
CAS No.2007919-26-6
PubChem CID127263576

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNJQV873 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNJQV873 route product structure diagram
    ACNJQV8732007919-26-6 In Stock
Inquiry

2. ACNJQV873 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNJQV873 route product structure diagram
    ACNJQV8732007919-26-6 In Stock
Inquiry

Comments (0)